Arvinas Inc (ARVN)
33.16
+0.92
(+2.85%)
USD |
NASDAQ |
May 31, 16:00
33.14
-0.02
(-0.06%)
After-Hours: 20:00
Arvinas Accounts Payable (Quarterly): 17.80M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 17.80M |
December 31, 2023 | 17.80M |
September 30, 2023 | 34.30M |
June 30, 2023 | 6.70M |
March 31, 2023 | 12.30M |
December 31, 2022 | 5.70M |
September 30, 2022 | 7.90M |
June 30, 2022 | 12.30M |
March 31, 2022 | 8.60M |
December 31, 2021 | 31.30M |
September 30, 2021 | 4.672M |
June 30, 2021 | 4.975M |
March 31, 2021 | 9.003M |
Date | Value |
---|---|
December 31, 2020 | 7.10M |
September 30, 2020 | 5.088M |
June 30, 2020 | 2.430M |
March 31, 2020 | 3.021M |
December 31, 2019 | 4.557M |
September 30, 2019 | 2.278M |
June 30, 2019 | 1.412M |
March 31, 2019 | 1.564M |
December 31, 2018 | 2.758M |
September 30, 2018 | 1.301M |
June 30, 2018 | 1.657M |
December 31, 2017 | 0.5965M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.412M
Minimum
Jun 2019
34.30M
Maximum
Sep 2023
9.962M
Average
6.90M
Median
Accounts Payable (Quarterly) Benchmarks
Pfizer Inc | 5.591B |
Bristol-Myers Squibb Co | 3.539B |
Alnylam Pharmaceuticals Inc | 78.15M |
Rhythm Pharmaceuticals Inc | 7.55M |
IDEAYA Biosciences Inc | 6.29M |